Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis
- PMID: 19009508
- DOI: 10.1177/039139880803101006
Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis
Abstract
Aim: Changes in plasma immunoreactive insulin (IRI) and connecting-peptide immunoreactivity (CPR) concentrations during hemodialysis (HD) were evaluated in diabetic HD patients with 3 different high-flux membranes. The removal properties of the membranes were compared.
Method: In this prospective controlled study, 15 stable diabetic patients on HD were randomly selected for 6 HD sessions with 3 different membranes: polysulfone (PS), cellulose triacetate (CTA), and polymethylmethacrylate (PMMA). Blood samples were obtained from the blood tubing at the arterial (A) site at the beginning and end of the sixth HD session. At 60 minutes after dialysis initiation, blood samples were obtained from both the A and venous (V) sites of the dialyzer to investigate the clearance and removal properties of the membranes.
Results: The plasma IRI and CPR levels decreased significantly at each time point with all 3 membranes. IRI clearance with the PS membrane was significantly higher than that with the CTA and PMMA membranes. No difference was observed in the IRI reduction rate between the 3 membranes. CPR clearance and reduction rate with the PMMA membrane were lower than with the PS and CTA membranes. No significant difference was observed in serum creatinine clearance and reduction rates between the 3 membranes; however, serum urea nitrogen clearance was significantly lower with the PMMA membrane compared with the PS and CTA membranes. A significantly high beta2-microglobulin clearance and reduction rate was achieved in the order PS > CTA > PMMA.
Conclusion: Plasma IRI and CPR are cleared by HD; their clearance rates differ with the dialyzer membranes. Plasma IRI clearance with the PS membrane is higher than that with the CTA and PMMA membranes.
Similar articles
-
Kinetics of Glucoregulatory Peptide Hormones during Hemodialysis with Cellulose Triacetate and Polysulfone Dialyzers in Patients with Diabetes and End-Stage Kidney Disease.Int J Mol Sci. 2023 Jun 25;24(13):10604. doi: 10.3390/ijms241310604. Int J Mol Sci. 2023. PMID: 37445782 Free PMC article.
-
The influence of hemodialysis membranes on the plasma insulin level of diabetic patients on maintenance hemodialysis.Clin Nephrol. 2008 May;69(5):354-60. doi: 10.5414/cnp69354. Clin Nephrol. 2008. PMID: 18538098 Clinical Trial.
-
Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis.Artif Organs. 2011 Apr;35(4):398-403. doi: 10.1111/j.1525-1594.2010.01112.x. Epub 2011 Feb 14. Artif Organs. 2011. PMID: 21314833
-
Hemodialysis membranes for acute and chronic renal insufficiency.Curr Neurovasc Res. 2013 Aug;10(3):263-8. doi: 10.2174/15672026113109990018. Curr Neurovasc Res. 2013. PMID: 23782098 Review.
-
Reactions to Synthetic Membranes Dialyzers: Is there an Increase in Incidence?Kidney Blood Press Res. 2019;44(5):907-914. doi: 10.1159/000501035. Epub 2019 Sep 10. Kidney Blood Press Res. 2019. PMID: 31505506 Review.
Cited by
-
Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study.BMC Nephrol. 2013 Apr 4;14:80. doi: 10.1186/1471-2369-14-80. BMC Nephrol. 2013. PMID: 23557110 Free PMC article. Clinical Trial.
-
Kinetics of Glucoregulatory Peptide Hormones during Hemodialysis with Cellulose Triacetate and Polysulfone Dialyzers in Patients with Diabetes and End-Stage Kidney Disease.Int J Mol Sci. 2023 Jun 25;24(13):10604. doi: 10.3390/ijms241310604. Int J Mol Sci. 2023. PMID: 37445782 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical